Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma

Clinical Cancer Research

Volumn 6, Issue 3, 2000, Pages 790-797

  Herbst, Roy S ^a   Yano, Seiji ^a   Kuniyasu, Hiroki ^a   Khuri, Fadlo R ^a   Bucana, Corazon D ^a   Guo, Fang ^a   Liu, Diane ^a   Kemp, Bonnie ^a   Lee, J Jack ^a   Hong, Waun Ki ^a   Fidler, Isaiah J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GELATINASE A; GELATINASE B; INTERLEUKIN 8; UVOMORULIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CELL LEVEL; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ADULT; AGED; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS;

EID: 0034103550     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Martini, N., McCaughan, B. C., and McCormack, P. Lobectomy for stage I lung cancer. In: C. F. Kittle (ed.), Current Controversies in Thoracic Surgery, pp. 171-174. Philadelphia: W. B. Saunders Company, 1986.
2. Williams, D. E., Pairolero, P. C., Davis, C. S., Bernatz, P. E., Payne, W. S., Taylor, W. F., Uhlenhopp, M. A., and Fontana, R. S. Survival of patients surgically treated for stage I lung cancer. J. Thorac. Cardiovasc. Surg., 82: 70-76, 1981.
3. Teramachi, M., Miyamoto, N., Sasaka, T., Nakamura, T., and Kitamura, F. Results of surgery in non-small cell lung cancer. Bull. Chest Dis. Res. Inst. Kyoto Univ., 23: 48-53, 1990.
4. Naruke, T., Goya, T., Tsuchiya, R., and Suemasu, K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J. Thorac. Cardiovasc. Surg., 96: 440-447, 1988.
5. Slebos, R. J., Kibbelaar, R. E., Dalesio, O., Kooistra, A., Stam, J., Meijer, C. J., Wagenaar, S. S., Vanderschueren, R. G., van Zandwijk, N., and Moot, W. J. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med., 323: 561-565, 1990.
6. Lee, J. S., Ro, J. Y., Sahin, A. A., Hong, W. K., Brown, B. W., Mountain, C. F., and Hittelman, W. N. Expression of blood-group antigen A-a favorable prognostic factor in non-small-cell lung cancer. N. Engl. J. Med., 324: 1084-1090, 1991.
7. Pezzella, F., Turley, H., Kuzu, I., Tungekar, M. F., Dunnill, M. S., Pierce, C. B., Harris, A., Gatter, K. C., and Mason, D. Y. Bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med., 329: 690-694, 1993.
8. Harpole, D. H., Herndon, J. E., and Young, W. G. Stage I non-small cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence. Cancer (Phila.), 76: 787-796, 1995.
9. Kwiatkowski, D. J., Harpole, D. H., Jr., Godleski, J., Herndon, J. E., II, Shieh, D. B., Richards, W., Blanco, R., Xu, H. J., Strauss, G. M., and Sugarbaker, D. J. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications. J. Clin. Oncol., 16: 2468-2477, 1998.
10. Mehdi, S. A., Tatum, A. H., Newman, N. B., Gamble, G. P., Etzell, J. E., Weidner, H., Kern, J. A., Sorscher, S. M., Kohman, L. J., and Graziano, S. L. Prognostic markers in resected stage I and II non-small cell lung cancer: an analysis of 260 patients with 5 year follow-up. Clin. Lung Cancer, 1: 59-67, 1999.
11. Pastorino, U., Andreola, S., Tagliabue, E., Pezzella, F., Incarbone, M., Sozzi, G., Buyse, M., Menard, S., Pierotti, M., and Rilke, F. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J. Clin. Oncol., 15: 2858-2865, 1997.
12. Fontanini, G., Boldrini, L., Chine, S., Pisaturo, F., Basolo, F., Calcinai, A., Lucchi, M., Mussi, A., Angeletti, C. A., and Bevilacqua, G. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas. Br. J. Cancer, 79: 363-369, 1999.
13. Fontanini, G., Lucchi, M., Vignati, S., Mussi, A., Ciardiello, F., De Laurentis, M., De Placido, S., Basolo, F., and Angeletti, C. A. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J. Natl. Cancer Inst., 89: 881-886, 1997.
14. Fontanini, G., Bigini, D., Vignati, S., Basolo, F., Mussi, A., Lucchi, M., Chine, S., Angeletti, C. A., Harris, A. L., and Bevilacqua, G. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J. Pathol., 177: 57-63, 1995.
15. Fidler, I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G. H. A. Clowes Memorial Award Lecture. Cancer Res., 50: 6130-6138, 1990.
16. Fidler, I. J., Kumar, R., Bielenberg, D. R., and Ellis, L. M. Molecular determinants of angiogenesis in cancer metastasis. Cancer J. Sci. Am., 4: S58-S66, 1998.
17. Fidler, I. J. Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother. Pharmacol., 43: S3-S10, 1999.
18. Radinsky, R., Bucana, C. D., Ellis, L. M., Sanchez, R., Cleary, K. R., Brigati, D. J., and Fidler, I. J. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res., 53: 937-943, 1993.
19. Fidler, I. J., and Radinsky, R. Genetic control of cancer metastasis. J. Natl. Cancer Inst., 82: 166-168, 1990.
20. Bucana, C. D., Fabra, A., Sanchez, R., and Fidler, I. J. Different patterns of macrophage infiltration into allogeneic-murine and xenogeneic-human neoplasms growing in nude mice. Am. J. Pathol., 141: 1225-1236, 1992.
21. Kitadai, Y., Ellis, L. M., Tucker, S. L., Greene, G. F., Bucana, C. D., Cleary, K. R., Takahashi, Y., Tahara, E., and Fidler, I. J. Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma. Am. J. Pathol., 149: 1541-1551, 1996.
22. Kitadai, Y., Ellis, L. M., Takahashi, Y., Bucana, C. D., Anzai, H., Tahara, T., and Fidler, I. J. Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. Clin. Cancer Res., 1: 1095-1102, 1995.
23. Kitadai, Y., Bucana, C. D., Ellis, L. M., Anzai, H., Tahara, E., and Fidler, I. J. In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. Am. J. Pathol., 147: 1238-1247, 1995.
24. Anzai, H., Kitadai, Y., Bucana, C. D., Sanchez, R., Omoto, R., and Fidler, I. J. Expression of metastasis-related genes in surgical specimens of human gastric cancer can predict disease recurrence. Eur. J. Cancer, 34: 558-565, 1998.
25. Greene, G. F., Kitadai, Y., Pettaway, C. A., von Eschenbach, A. C., and Fidler, I. J. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am. J. Pathol., 150: 1571-1582, 1997.
26. Kuniyasu, H., Ellis, L. M., Evans, D. B., Abbruzzese, J. L., Fenoglio, C. J., Bucana, C. D., Cleary, K. R., Tahara, E., and Fidler, I. J. Relative expression of E-cadherin and type IV collagenase genes prediets disease outcome in patients with resectable pancreatic carcinoma. Clin. Cancer Res., 5: 25-33, 1999.
27. Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Marmer, B. L., Grant, G. A., Seltzer, J. L., Kronberger, A., He, C. S., Bauer, E. A., and Goldbert, G. I. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem., 263: 6579-6587, 1988.
28. Singh, R. K., Gutman, M., Radinsky, R., Bucana, C. D., and Fidler, I. J. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res., 54: 3242-3247, 1994.
29. Singh, R. K., and Fidler, I. J. Regulation of tumor angiogenesis by organ-specific cytokines. Curr. Top. Microbiol. Immunol., 213: 1-11, 1996.
30. Li, L. M., Nicolson, G. L., and Fidler, I. J. Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res., 51: 245-254, 1991.
31. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266: 11947-11954, 1991.
32. Matsuyama, K., Chiba, Y., Sasaki, M., Tahaka, H., Muraoka, R., and Tanigawa, N. Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer. Ann. Thorac. Surg., 65: 1405-1409, 1998.
33. Bussemakers, M. J., van Bokhoven, A., Mees, S. G., Kemler, R., and Schalken, J. A. Molecular cloning and characterization of the human E-cadherin cDNA. Mol. Biol. Rep., 17: 123-128, 1993.
34. Pearson, W. R., and Lipman, D. J. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA, 85: 2444-2448, 1988.
35. Park, C-S., Manahan, I. J., and Brigati, D. J. Automated molecular pathology: one hour in situ DNA hybridization. J. Histotechnol., 14: 219-229, 1991.
36. McCurley, C. R., Shivers, R. R., and Del Maestro, R. F. Quantitative comparison of the morphology of the microvasculature of primary lung lesions and metastatic brain tumours. J. Submicrosc. Cytol. Pathol., 30: 257-269, 1998.
37. Caruthers, M. H., Beaucage, S. L., Efcavitch, J. W., Fisher, E. F., Goldman, R. A., de Haseth, P. L., Mandecki, W., Matteucci, M. D., Rosendahl, M. S., and Stabinsky, Y. Chemical synthesis and biological studies on mutated gene-control regions. Cold Spring Harbor Symp. Quant. Biol., 47: 411-418, 1983.
38. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc., 53: 457-481, 1958.
39. Bucana, C. D., Radinsky, R., Dong, Z., Sanchez, R., Brigati, D. J., and Fidler, I. J. A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells. J. Histochem. Cytochem., 41: 499-506, 1993.
40. Kitadai, Y., Haruma, K., Sumii, K., Yamamoto, S., Ue, T., Yokozaki, H., Yasui, W., Ohmoto, Y., Fidler, I. J., Tahara, E., and Kajiyama, G. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am. J. Pathol., 152: 93-100, 1998.
41. Fidler, I. J., and Kripke, M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science (Washington DC), 197: 893-895, 1977.
42. Altman, D. G., Lausen, B., Sauerbrei, W., and Schumacher, M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J. Natl. Cancer Inst., 86: 829-835, 1994.
43. Takeichi, M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science (Washington DC), 257: 1451-1455, 1991.
44. Takeichi, M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development (Camb.), 102: 639-655, 1988.
45. Shimoyama, Y., Hirohashi, S., Hirano, S., Noguchi, M., Shimosato, Y., Takeichi, M., and Abe, O. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res., 49: 2128-2133, 1989.
46. Shimoyama, Y., and Hirohashi, S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res., 51: 2185-2192, 1991.
47. Vleminckx, K., Vakaet, L., Jr., Mareel, M., Fiers, W., and van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66: 107-119, 1991.
48. Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 284: 67-68, 1980.
49. Liotta, L. A., and Stetler-Stevenson, W. G. Metalloproteinases and cancer invasion. Semin. Cancer Biol., 1: 99-106, 1990.
50. Matrisian, L. M., and Bowden, G. T. Stromelysin/transin and tumor progression. Semin. Cancer Biol., 1: 107-115, 1990.
51. Schipper, J. H., Frixen, U. H., Behrens, J., Unger, A., Jahnke, K., and Birchmeier, W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res., 51: 6328-6337, 1991.
52. Oka, H., Shiozaki, H., Kobayashi, K., Inoue, M., Tahara, H., Kobayashi, T., Takatsuka, Y., Matsuyoshi, N., and Hirano, S. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res., 53: 1696-1701, 1993.
53. Imoto, H., Osaki, T., Taga, S., Ohgami, A., Ichiyoshi, Y., and Yasumoto, K. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. J. Thorac. Cardiovasc. Surg., 115: 1007-1014, 1998.
54. Takanami, I., Tanaka, F., Hashizume, T., and Kodaira, S. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. Anticancer Res., 17: 2811-2814, 1997.
55. Singh, R. K., Bucana, C. D., Gutman, M., Fan, D., Wilson, M. R., and Fidler, I. J. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am. J. Pathol., 145: 365-374, 1994.
56. Rogelj, S., Weinberg, R. A., Fanning, P., and Klagsbrun, M. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature (Lond.), 331: 173-175, 1988.
57. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrera, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Washington DC), 246: 1306-1309, 1989.
58. Matsushima, K., Morishita, K., Yoshimura, T., Lavu, S., Kobayashi, Y., Lew, W., Appella, E., King, H. F., Leonard, E. J., and Oppenheim, J. J. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med., 167: 1883-1893, 1988.